Pyxis Oncology, Inc. (PYXS) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
10/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinPYXS / S&P 106.16% / 15.20% |
LosePYXS / S&P PYXS unavailable / 15.00% |
LosePYXS / S&P -11.32% / 50.40% |
| 2026-Q11/3 |
WinPYXS / S&P 26.96% / -4.33% |
LosePYXS / S&P PYXS unavailable / 11.30% |
LosePYXS / S&P -17.09% / 27.70% |
| 2025-Q40/3 |
LosePYXS / S&P -48.20% / 2.65% |
LosePYXS / S&P PYXS unavailable / 9.00% |
LosePYXS / S&P 0.00% / 13.40% |
| 2025-Q32/3 |
WinPYXS / S&P 101.82% / 8.12% |
LosePYXS / S&P PYXS unavailable / 4.61% |
WinPYXS / S&P 54.37% / 13.45% |
| 2025-Q22/3 |
WinPYXS / S&P 12.24% / 10.94% |
LosePYXS / S&P PYXS unavailable / 4.83% |
WinPYXS / S&P 28.23% / 10.63% |
| 2025-Q11/3 |
LosePYXS / S&P -37.18% / -4.27% |
LosePYXS / S&P PYXS unavailable / 4.98% |
WinPYXS / S&P 16.18% / 10.57% |
| 2024-Q40/3 |
LosePYXS / S&P -57.49% / 2.41% |
LosePYXS / S&P PYXS unavailable / 5.25% |
LosePYXS / S&P -29.89% / 6.15% |
| 2024-Q31/3 |
WinPYXS / S&P 10.88% / 5.89% |
LosePYXS / S&P PYXS unavailable / 5.89% |
LosePYXS / S&P -59.61% / 6.11% |
| 2024-Q20/3 |
LosePYXS / S&P -22.30% / 4.28% |
LosePYXS / S&P PYXS unavailable / 5.38% |
LosePYXS / S&P -56.34% / 5.12% |
| 2024-Q11/3 |
WinPYXS / S&P 136.67% / 10.56% |
LosePYXS / S&P PYXS unavailable / 5.71% |
LosePYXS / S&P -57.76% / 5.59% |
| 2023-Q40/3 |
LosePYXS / S&P -9.55% / 11.69% |
LosePYXS / S&P PYXS unavailable / 6.81% |
LosePYXS / S&P -49.59% / 7.78% |
| 2023-Q30/3 |
LosePYXS / S&P -22.27% / -3.27% |
LosePYXS / S&P PYXS unavailable / 7.52% |
LosePYXS / S&P -108.88% / -5.03% |
| 2023-Q20/3 |
LosePYXS / S&P -36.16% / 8.74% |
LosePYXS / S&P PYXS unavailable / 9.50% |
LosePYXS / S&P -113.79% / -8.57% |
| 2023-Q11/3 |
WinPYXS / S&P 199.25% / 7.50% |
LosePYXS / S&P PYXS unavailable / 10.77% |
LosePYXS / S&P -120.32% / -15.69% |
| 2022-Q40/3 |
LosePYXS / S&P -31.98% / 7.56% |
LosePYXS / S&P PYXS unavailable / 11.88% |
LosePYXS / S&P PYXS unavailable / -17.99% |
| 2022-Q30/3 |
LosePYXS / S&P -17.23% / -4.88% |
LosePYXS / S&P PYXS unavailable / 13.47% |
LosePYXS / S&P PYXS unavailable / -1.41% |
| 2022-Q20/3 |
LosePYXS / S&P -41.09% / -16.10% |
LosePYXS / S&P PYXS unavailable / 13.71% |
LosePYXS / S&P PYXS unavailable / 11.04% |
| 2022-Q10/3 |
LosePYXS / S&P -63.17% / -4.60% |
LosePYXS / S&P PYXS unavailable / 15.97% |
LosePYXS / S&P PYXS unavailable / 42.23% |
| 2021-Q40/3 |
LosePYXS / S&P PYXS unavailable / 11.03% |
LosePYXS / S&P PYXS unavailable / 15.00% |
LosePYXS / S&P PYXS unavailable / 96.40% |
| 2021-Q30/3 |
LosePYXS / S&P PYXS unavailable / 0.58% |
LosePYXS / S&P PYXS unavailable / 10.77% |
LosePYXS / S&P PYXS unavailable / 69.42% |
| 2021-Q20/3 |
LosePYXS / S&P PYXS unavailable / 8.55% |
LosePYXS / S&P PYXS unavailable / 6.58% |
LosePYXS / S&P PYXS unavailable / 51.81% |
| 2021-Q10/3 |
LosePYXS / S&P PYXS unavailable / 6.17% |
LosePYXS / S&P PYXS unavailable / -1.06% |
LosePYXS / S&P PYXS unavailable / 7.39% |
| 2020-Q40/3 |
LosePYXS / S&P PYXS unavailable / 12.15% |
LosePYXS / S&P PYXS unavailable / -3.72% |
LosePYXS / S&P PYXS unavailable / -33.42% |
| 2020-Q30/3 |
LosePYXS / S&P PYXS unavailable / 8.93% |
LosePYXS / S&P PYXS unavailable / -2.04% |
LosePYXS / S&P PYXS unavailable / -27.10% |
| 2020-Q20/3 |
LosePYXS / S&P PYXS unavailable / 20.54% |
LosePYXS / S&P PYXS unavailable / -0.46% |
LosePYXS / S&P PYXS unavailable / -27.11% |
| 2020-Q10/3 |
LosePYXS / S&P PYXS unavailable / -19.60% |
LosePYXS / S&P PYXS unavailable / 3.47% |
LosePYXS / S&P PYXS unavailable / -14.75% |
| 2019-Q40/3 |
LosePYXS / S&P PYXS unavailable / 9.07% |
LosePYXS / S&P PYXS unavailable / 5.36% |
LosePYXS / S&P PYXS unavailable / 2.99% |
| 2019-Q30/3 |
LosePYXS / S&P PYXS unavailable / 1.70% |
LosePYXS / S&P PYXS unavailable / 5.02% |
LosePYXS / S&P PYXS unavailable / 0.21% |
| 2019-Q20/3 |
LosePYXS / S&P PYXS unavailable / 4.30% |
LosePYXS / S&P PYXS unavailable / 6.64% |
LosePYXS / S&P PYXS unavailable / 8.65% |
| 2019-Q10/3 |
LosePYXS / S&P PYXS unavailable / 13.65% |
LosePYXS / S&P PYXS unavailable / 8.12% |
LosePYXS / S&P PYXS unavailable / 14.29% |
| 2018-Q40/3 |
LosePYXS / S&P PYXS unavailable / -13.52% |
LosePYXS / S&P PYXS unavailable / 9.05% |
LosePYXS / S&P PYXS unavailable / 18.23% |
| 2018-Q30/3 |
LosePYXS / S&P PYXS unavailable / 7.71% |
LosePYXS / S&P PYXS unavailable / 10.21% |
LosePYXS / S&P PYXS unavailable / 19.06% |
| 2018-Q20/3 |
LosePYXS / S&P PYXS unavailable / 3.43% |
LosePYXS / S&P PYXS unavailable / 9.03% |
LosePYXS / S&P PYXS unavailable / 14.46% |
| 2018-Q10/3 |
LosePYXS / S&P PYXS unavailable / -0.76% |
LosePYXS / S&P PYXS unavailable / 7.68% |
LosePYXS / S&P PYXS unavailable / 12.46% |
| 2017-Q40/3 |
LosePYXS / S&P PYXS unavailable / 6.64% |
LosePYXS / S&P PYXS unavailable / 7.03% |
LosePYXS / S&P PYXS unavailable / 13.82% |
| 2017-Q30/3 |
LosePYXS / S&P PYXS unavailable / 4.48% |
LosePYXS / S&P PYXS unavailable / 5.68% |
LosePYXS / S&P PYXS unavailable / 17.57% |
| 2017-Q20/3 |
LosePYXS / S&P PYXS unavailable / 3.09% |
LosePYXS / S&P PYXS unavailable / 4.83% |
LosePYXS / S&P PYXS unavailable / 17.74% |
| 2017-Q10/3 |
LosePYXS / S&P PYXS unavailable / 6.07% |
LosePYXS / S&P PYXS unavailable / 3.67% |
LosePYXS / S&P PYXS unavailable / 13.32% |
| 2016-Q40/3 |
LosePYXS / S&P PYXS unavailable / 3.82% |
LosePYXS / S&P PYXS unavailable / 2.09% |
LosePYXS / S&P PYXS unavailable / 7.05% |
| 2016-Q30/3 |
LosePYXS / S&P PYXS unavailable / 3.85% |
LosePYXS / S&P PYXS unavailable / 0.20% |
LosePYXS / S&P PYXS unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PYXS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 159.38% | 20.78% |
| Annualized return | 159.38% | 20.78% |
5Y · 2021-10-08 to 2026-08-27
| Metric | PYXS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -74.85% | 83.14% |
| Annualized return | -24.12% | 12.86% |
10Y · 2021-10-08 to 2026-08-27
| Metric | PYXS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -74.85% | 319.30% |
| Annualized return | -12.89% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |